1. Introduction {#sec1}
===============

Central serous chorioretinopathy (CSC) is a posterior segment disease characterized by the serous detachment of the neurosensory retina in the macular area \[[@B1]\]. CSC occurs in 9.9 per 100,000 men and 1.7 per 100,000 women, six times more frequently in men than in women \[[@B2]\]. This disease can be classified as acute (less than three to six months in duration) or chronic (longer term) \[[@B3]\]. As a benign and self-limiting disease, most acute CSC cases last only between two and three months \[[@B4]\]; however, CSC recurs in approximately one-third of recovered patients \[[@B5]\]. The symptoms of acute CSC are related to the localization of the subretinal detachment around the macular area and limited focal or multifocal retinal pigment epithelium (RPE) alterations. Chronic CSC may also cause severe loss of visual acuity and decreased light sensitivity \[[@B6]\].

Advances in imaging techniques, such as fluorescein fundus angiography (FFA) and indocyanine green angiography (ICGA), have enabled researchers to obtain a better understanding of the anatomical structural alterations occurring in CSC. They include disturbed choroidal circulation and retinal pigment epithelium (RPE) which are the primary changes associated with this disease. The current understanding of the pathophysiology of CSC involves choroidal vascular hyperpermeability, which leads to increased tissue hydrostatic pressure beneath the RPE and discontinuity of the RPE \[[@B7]\]. ICGA findings showed staining of the inner choroid in the midphase of the angiogram, suggesting that choroidal vascular hyperpermeability may arise from venous congestion and ischemia \[[@B8]\]. Some studies found that patients affected by CSC often have higher levels of serum and urinary cortisol and catecholamines than do healthy subjects and therapies with local or systemic steroids can cause the disease \[[@B9]--[@B11]\]. Glucocorticoid elevations were also identified as the primary risk factor for the onset of CSC \[[@B12]--[@B14]\]. However, some regions of the retina may show signs of increased choroidal hyperpermeability but are not linked to manifestations of CSC \[[@B8]\]. Additionally, Turkcu et al. found that the antioxidant capacity decreased significantly in CSC cases, which implies that the oxidative process is involved in the pathogenesis of CSC \[[@B15]\].

Because the choroidal vessels contribute greatly to CSC pathophysiology and the ophthalmic artery supplies the retinal circulation, this study investigated whether altered retinal circulation was also related to CSC. Noninvasive spectrophotometric retinal oximetry has been used to measure oxygen saturation in retinal arterioles and venules \[[@B16]\]. This method was applied to determine whether there is an association between changes in retinal vessel oxygen saturation and the vessel diameter around the macular region in patients with CSC. In this study, we used a noninvasive retinal oximeter to measure oxygen saturation in retinal vessels in patients with CSC to detect retinal oxygen metabolic changes.

2. Materials and Methods {#sec2}
========================

The study protocol was reviewed and approved by the Sun Yat-sen University Medical Ethics Committee (Zhongshan Ophthalmic Center Medical Ethics (2013) number 07). The protocol strictly adhered to the principles of the World Medical Association\'s Declaration of Helsinki. Informed consent was obtained from all subjects before examinations were performed.

2.1. Subjects {#sec2.1}
-------------

The study included the following: 33 CSC patients, of which 20 patients were diagnosed with acute CS and 13 patients were diagnosed with chronic CSC. The inclusion criteria for the CSC patients were the following: Chinese (xanthoderm origin), one eye featuring typical funduscopic appearance for CSC, normal binocular intraocular pressure (10--21 mmHg), and no other ocular disease or history of eye surgery. The manifestations of CSC include serous retinal detachment as well as RPE detachment or dysfunction without evidence of any other possible cause of exudation, such as inflammation, infiltration, or choroidal neovascularization. The eligible patients were those in whom only one eye exhibited manifestations of CSC, and their contralateral eyes were measured as the control.

Exclusion criteria were as follows: congestive heart failure, diabetes mellitus, coronary artery disease, uncontrolled arterial hypertension, hyperlipidemia, tumors, autoimmune and inflammatory diseases, renal and hepatic disorders, endocrine pathology, and concomitant treatment affecting androgen metabolism (statins and calcium antagonists) as well as drug and/or alcohol abuse. Additionally, subjects with ametropia of greater than 3D or anisometropia of less than 1D were excluded.

All patients were diagnosed by the same ophthalmologist and diagnoses were verified according to the images from fluorescein angiography and optical coherence tomography (OCT). Additionally, all participants underwent complete ophthalmic examinations consisting of the best-corrected visual acuity (LogMAR visual acuity chart), refraction, and intraocular pressure (IOP) examined using a noncontact tonometer (NCT) (Canon TX-20), a slit-lamp examination (Suzhou YZ5S), fundoscopy (Topcon TRC-50DX), and OCT (Topcon 3D OCT-1000). Finger pulse oximetry (Biolight M70), blood pressure, and heart rate (BangPu BF-1100) were measured before retinal oximetry. The ocular perfusion pressure (OPP) was calculated using the following equation: $$\begin{matrix}
{OPP = \left( \frac{2}{3} \right)\left( {\left( \frac{2}{3} \right){BP}_{diast} + \left( \frac{1}{3} \right){BP}_{syst}} \right) - IOP,} \\
\end{matrix}$$where BP~diast~ and BP~syst~ are the diastolic blood pressure and systolic blood pressure, respectively \[[@B17]\].

Complete medical histories were obtained for all test patients, including hormonal abnormalities, renal disease, hypertension, smoking, and medications that may alter hormonal status, such as glucocorticoids, statins, blockers, psychotropics, hormonal replacement therapy, or hormonal inhibitors.

2.2. Retinal Oximetry {#sec2.2}
---------------------

The retinal oximeter used in this study (Oxymap ehf., Reykjavik, Iceland) has been described in detail previously \[[@B18]\]. It features a fundus camera base coupled with a beam splitter and a digital camera, yielding fundus images at two light wavelengths simultaneously. Specialized software automatically selects the measurement points on the oximetry images and calculates the optical density (absorbance) of the retinal vessels at two wavelengths, 600 nm and 570 nm. The optical density is sensitive to oxygen saturation at 600 nm; however, the optical density is not sensitive to oxygen saturation at the reference wavelength of 570 nm. The ratio of these optical densities is approximately linearly related to the hemoglobin oxygen saturation. The oximeter was calibrated to yield the relative oxygen saturation values. The calibration is not perfect, however, and in some cases, the measurement exceeds 100%. The oximeter is sensitive to changes in oxygen saturation and to yield repeatable results. The oximetry values obtained may thus be used for comparison, although they may differ from the absolute saturation values.

The pupils of each subject were dilated with 0.5% tropicamide (Shenyang Xingji Co., Shenyang, China) for at least 15 minutes before retinal oximetry measurements or until the pupils were dilated to 5.5 to 6.0 mm in diameter. The same skilled photographer took images in a dark room; light was provided only from the fundus camera and the computer screen. The standard procedure and parameters were the following: (1) lowest illumination intensity, (2) flash intensity = 50 W·s \[[@B19]\], (3) small aperture and small pupil, (4) consistent angle of gaze with optic disc located at the image center, and (5) consistent order of photographs (right eye first, three images for each eye). The time between the images was approximately 1 minute, and the best quality image with the optic disc in the center was selected for analysis.

2.3. Image Analysis {#sec2.3}
-------------------

The oxygen saturation and the width of the retinal vessels were analyzed automatically using the Oxymap Analyser version 2.0 specialized software, and at the same time, it measured the fundus image quality, which takes into account overall quality, focus, and contrast. The analyzer treated oximetry images from the affected eyes and contralateral eyes equally. The pseudocolor fundus image provides a quick overview of the saturation distribution in the retinal vessels ([Figure 1](#fig1){ref-type="fig"}). The retinal oxygen levels of the optic disc area and macular region (the arterioles and the venules) were measured separately.

The vessel selection method was the following. Using the center of the optic disc as the origin, one small circle just on the rim of the optic disc and another circle three times larger were drawn on the pseudocolor fundus images of all patients. The vessels between the two circles were selected to be analyzed overall and in four quadrants, that is, the superonasal quadrant (NS), the inferonasal quadrant (NI), the inferotemporal quadrant (TI), and the superotemporal quadrant (TS). This is the method that Geirsdottir et al. used \[[@B20]\] to measure the oxygen saturation in the optic disc area. Then, the arterioles and the venules between the superior and the inferior vessel arches were analyzed. The first and second branches of the vessels with widths of eight or more pixels were selected for analysis. The images and selection methods are shown in [Figure 1](#fig1){ref-type="fig"}.

2.4. Statistical Analyses {#sec2.4}
-------------------------

Statistical analyses were performed using the program SPSS 10.0 for Windows. Descriptive statistics were calculated for clinical data. For the statistical analysis between affected eyes and contralateral eyes, the paired *t*-test or Wilcoxon matched pair signed rank sum test was employed to evaluate group difference significance between different quadrants according to their distribution test results (Shapiro--Wilk test; *α* = 0.05): paired *t*-test for normality, Wilcoxon matched pair signed rank sum test for abnormal distribution. The data are expressed as mean ± standard deviation. All statistical tests were two sided, and *p* \< 0.05 was considered statistically significant. For the statistical analysis between acute and chronic patients, the statistic method used was the unpaired *t*-test or rank sum test (Mann--Whitney *U* test) depending on the distribution of the data (Shapiro--Wilk test; *α* = 0.05) and homogeneity of variance (*F* test; *α* = 0.05): the unpaired t-test was used for normal distribution and homogeneous variance, while the rank sum test (Mann--Whitney *U* test) was used for abnormal distribution or inhomogeneous variance.

3. Results {#sec3}
==========

A total of 33 single eye-affected patients were recruited for the retinal vessel oxygen measurements with the contralateral eyes serving as the control. The systemic conditions and eye measurement data are shown in [Table 1](#tab1){ref-type="table"}.

Because CSC is six times more common in men than in women \[[@B2]\], most of the clinic patients were men; only five women were included in this study. This difference in prevalence is consistent with that in other studies.

The Oxymap Analyser software generated three image quality scores for each image based on overall quality, focus, and contrast. Out of these images, only one patient\'s fundus image quality assessment was less than 6. In his affected eye, overall assessment was 5 and focus assessment was 5.5, while in the contralateral eye, overall assessment was 5.1. Most of the patients scored more than 7, and five patients scored between 6 and 7. The difference in image quality between affected eyes and contralateral eyes was not significant; details are shown in [Figure 2](#fig2){ref-type="fig"} (overall: paired *t*-test, *p* value was 0.195; focus: paired *t*-test, *p* value is 0.400; contrast: Wilcoxon matched pair signed rank sum test, *p* value is 0.129).

First, we used Shapiro--Wilk test to assess the distribution of oxygen saturation and the changes in vessel diameters between affected eyes and contralateral eyes. Only the overall AS, NI AS, overall VS, and TS AVS were not normally distributed, and these were analyzed via the Wilcoxon matched pair signed rank sum test. The numerical values and statistical results for the overall optic disc area and four quadrants are shown in [Table 2](#tab2){ref-type="table"}.

Remarkably, the AS in the TI increased (93.2% ± 10.2%) compared to that in the contralateral eyes (88.7% ± 7.7%). In the NI of the affected eyes, the VS increased compared to that in the contralateral eyes, 61.3% ± 7.3% versus 56.9% ± 6.5%, respectively. On the contrary, in the NI, the AVS decreased (36.7% ± 10.4%) compared to that in the contralateral eyes (41.5% ± 11.2%), which means CSC causes oxygen consumption to rise. Additionally, VD in TI increased from 18.1 ± 3.4 pixels in the contralateral eyes to 19.9 ± 2.5 pixels in the affected eyes.

Because CSC primarily influences the macular area lying on the temporal side \[[@B8]\], the rise in oxygen saturation may be a result of alterations between macular area oxygen replenishment and consumption. To test this possibility, we also selected arterioles and venules between the superior and inferior vessel arches to analyze the oxygen saturation around the macular area. These results are shown in [Figure 3](#fig3){ref-type="fig"}. The arteriole oxygen saturation in the affected eyes is 93.6% ± 7.6%, while in the contralateral eyes, it is only 89.5% ± 6.3%, and the *p* value is 0.006 (Wilcoxon matched pair signed rank sum test). However, the AVS showed no significant change.

Then, we compared the acute and chronic CSC patients to determine whether the CSC type influenced the results. We compared the affected eyes between acute and chronic patients ([Table 3](#tab3){ref-type="table"}) and also compared the contralateral eyes ([Table 4](#tab4){ref-type="table"}) between acute and chronic patients. The areas compared are the overall area, the four quadrants of the optic disc, and the macular region. There was no significant difference in the oxygen saturation or vessel diameter between acute and chronic CSC patients overall, in the four optic disc quadrants, or in the macular region. And it also proved that it was reasonable to combine these data for analysis.

Additionally, using data from a previously published paper \[[@B18]\] from our group that considered 129 local healthy young people\'s oxygen and diameter data, we reanalyzed our data against data from patients in which neither eye shows CSC, and we found that in the CSC-affected eyes, AS obviously increased in the NS, TI, and TS quadrants, excepting only the NI quadrant, and the VS decreased in TI. As for diameter, the venules expanded in the NS, TI, and TS quadrants. At the same time, in the contralateral eyes, AS was higher in TS, and the VS was also lower than in healthy eyes in N and TI even though patients were not matched for age and gender. These data are shown in Supplementary Tables 1 available online at <https://doi.org/10.1155/2017/5972418> and 2.

4. Discussion {#sec4}
=============

We show here that retinal vessel saturation may change in CSC-affected eyes. When these levels in CSC-affected eyes were compared to those in the contralateral eyes of the same patient, changes were found in the TI AS and the NI VS, and the AS was moderately increased around the macular region. Additionally, the contralateral eyes had higher mean AS and lower mean VS in specific quadrants when compared to the eyes of healthy young Chinese from our previous study, despite not being matched for age and gender \[[@B18]\]. This implies that CSC, a systemic disease, may also have effects on the contralateral eyes, rendering them unhealthy. This complication may in turn hinder assessment of the actual changes caused by CSC.

Researchers have reported that during the process of CSC, the choroidal blood flow decreases and the subfoveal choroidal blood flow is abnormally regulated \[[@B21]\]. Therefore, if the change in retinal vessel oxygen saturation around the macular region in CSC is a result of a change in the retinal vessel blood flow, then such effects still need to be more rigorously evaluated. Moreover, it has been shown that the oxygen saturation levels changed in some other eye diseases as well. For example, AS was significantly higher in patients with retinitis pigmentosa (RP) than in normal subjects among 20- to 40-year-old subjects and in elderly subjects. However, AS was significantly lower in RP patients than it was in healthy subjects \[[@B17]\]. In patients with an ischemic branch due to retinal vein occlusion (BRVO), the occluded arteriole oxygen saturation increased compared to the saturation levels in vessels from the same quadrant in the contralateral eyes \[[@B22]\]. Our group also found decreased retinal arteriole saturation, a decreased difference in arteriovenous saturation, and a narrowing of retinal vessel diameter in highly myopic eyes \[[@B23]\]. These data show that changes in oxygen saturation levels are an essential component of eye diseases.

However, this pilot clinical study has some limitations. The changes that occurred in the eyes of CSC patients must be further verified. The changes in this study, while significant, are small and only exist in the quadrants inclusive of the macular area. The reliability of these measurements warrants future validation. Additionally, CSC is a disease related to systemic conditions, which makes it necessary to increase the sample size and add normal eyes from age- and gender-matched persons as controls in additional studies. The oximetry analysis of oxygen saturation is based on the absorption of two wavelengths of light. Such dependence can be problematic if changes occur in the fundus pigment or if cataracts are present. Specifically, changes in the blood component profiles during CSC can cause measurement errors, which may induce a false-positive conclusion when analyzing the AS around the macular region. Another limitation is that we could not perform consecutive oxygen saturation measurements during the disease process for comparison with data collected after recovery.

However, considering that there is currently no consensus on the optimal method of measuring oxygen saturation in the retinal vasculature, oximetry is still a relatively safe and effective way to obtain such measurements. In summary, the results provide valuable insight that will help to guide further research on CSC.

5. Conclusions {#sec5}
==============

This study shows that AS increased during the CSC process in TI regions within the optic disc area and around the macular region; in addition, VS decreased in NI, which provides data requiring further study to confirm that oxygen saturation changes play an important role in the CSC process.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Table 1. Comparison of oxygen saturation and vessel diameter between CSC affected eyes and healthy young people\'s normal eyes. Table 2. Comparison of oxygen saturation and vessel diameter between CSC patients\' contralateral eyes and healthy young people\'s normal eyes.
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![Fundus photograph, FFA, and the pseudocolor fundus image. (a), (b), and (c) are images of the contralateral eye of one patient, while (d), (e), and (f) are images of the CSC-affected eye from the same patient. (a) and (d) are fundus photograph images. (b) and (e) are fundus fluorescein angiography (FFA) images. The white arrow shows the leakage in the macular region of the CSC-affected eye. (c) and (f) are the pseudocolor fundus images. Vessels of four quadrants were selected between the two circles, and the red arrows show the arteries selected for measuring AS; similarly, the green arrows show the venules selected for measuring VS.](JOPH2017-5972418.001){#fig1}

![Image quality scores between the affected eyes and contralateral eyes. No difference was significant between the affected and contralateral eyes in overall quality, focus, or contrast scores. The paired *t*-test was used in the overall and focus comparison, resulting in *p* values of 0.194 and 0.400, respectively. The Wilcoxon matched pair signed rank sum test was used in the contrast comparison, resulting in a *p* value of 0.129.](JOPH2017-5972418.002){#fig2}

![Oxygen saturation and vessel diameters around the macular area. (a) Compared to the contralateral eyes, AS is increased in the affected eyes (*p* value of 0.006), but AVS shows no significant difference. ^∗^*p* \< 0.05 (AS: Wilcoxon matched pair signed rank sum test; VS, AVS: paired *t*-test). (b) Vessel diameters show no change. ^∗^*p* \< 0.05 (paired *t*-test).](JOPH2017-5972418.003){#fig3}

###### 

Characteristics of the study subjects.

  Variables                         Systemic conditions   Contralateral eyes   Affected eyes
  --------------------------------- --------------------- -------------------- ---------------
  Gender (male) *N* (%)             28 (85%)              ------               ------
  Gender (female) *N* (%)           5 (15%)               ------               ------
  Age (year)                        41 ± 8                ------               ------
  Systolic blood pressure (mmHg)    119 ± 16              ------               ------
  Diastolic blood pressure (mmHg)   80 ± 13               ------               ------
  Pulse                             79 ± 14               ------               ------
  Finger oximetry (%)               98 ± 1                ------               ------
  Visual acuity                     ------                1.0 ± 0.4            0.5 ± 0.3
  Intraocular pressure (mmHg)       ------                15 ± 3               15 ± 3
  Perfusion pressure (mmHg)         ------                55 ± 9               55 ± 9

###### 

Comparison between affected eyes and contralateral eyes.

               Variables     Affected eyes   Contralateral eyes   Statistical method   *p* value
  ------------ ------------- --------------- -------------------- -------------------- -----------
  AS (%)       Overall       96.6 ± 7.0      95.4 ± 6.7           Wilcoxon test        0.623
  NS           101.2 ± 7.9   98.9 ± 8.1      Paired *t*-test      0.054                
  NI           98.0 ± 10.2   98.5 ± 11.6     Wilcoxon test        0.993                
  TI           93.2 ± 10.2   88.7 ± 7.7      Paired *t*-test      0.049^∗^             
  TS           94.5 ± 8.0    93.1 ± 6.2      Paired *t*-test      0.238                
                                                                                       
  VS (%)       Overall       60.9 ± 6.2      58.8 ± 6.3           Wilcoxon test        0.053
  NS           62.4 ± 7.1    61.0 ± 7.6      Paired *t*-test      0.286                
  NI           61.3 ± 7.3    56.9 ± 6.5      Paired *t*-test      0.005^∗^             
  TI           53.4 ± 8.7    52.8 ± 9.0      Paired *t*-test      0.761                
  TS           61.1 ± 8.8    61.3 ± 8.6      Paired *t*-test      0.874                
                                                                                       
  AVS (%)      Overall       35.7 ± 6.5      36.6 ± 6.3           Paired *t*-test      0.508
  NS           38.8 ± 9.3    37.9 ± 9.7      Paired *t*-test      0.489                
  NI           36.7 ± 10.4   41.5 ± 11.2     Paired *t*-test      0.024^∗^             
  TI           39.8 ± 10.7   35.9 ± 9.9      Paired *t*-test      0.188                
  TS           33.4 ± 10.7   31.7 ± 8.5      Wilcoxon test        0.458                
                                                                                       
  AD (pixel)   Overall       13.0 ± 1.2      13.0 ± 1.2           Paired *t*-test      0.776
  NS           12.8 ± 1.8    13.0 ± 1.8      Paired *t*-test      0.683                
  NI           12.5 ± 1.8    12.7 ± 1.7      Paired *t*-test      0.56                 
  TI           13.8 ± 2.5    13.8 ± 2.5      Paired *t*-test      0.88                 
  TS           13.4 ± 2.0    14.2 ± 2.0      Paired *t*-test      0.071                
                                                                                       
  VD (pixel)   Overall       17.3 ± 1.4      16.8 ± 1.7           Paired *t*-test      0.105
  NS           17.1 ± 2.1    16.8 ± 2.2      Paired *t*-test      0.381                
  NI           15.8 ± 2.9    16.1 ± 2.8      Paired *t*-test      0.676                
  TI           19.9 ± 2.5    18.1 ± 3.4      Paired *t*-test      0.01^∗^              
  TS           18.1 ± 2.7    17.0 ± 2.8      Paired *t*-test      0.129                

^∗^ *p* \< 0.05.

###### 

Comparison of oxygen saturation and vessel diameter of the affected eyes between acute and chronic CSC patients.

                   Variables     Acute CSC     Chronic CSC              Statistical method   *p* value
  ---------------- ------------- ------------- ------------------------ -------------------- -----------
  AS (%)           Overall       97.1 ± 7.8    95.7 ± 5.8               Unpaired *t*-test    0.565
  NS               100.5 ± 7.3   102.3 ± 9.0   Unpaired *t*-test        0.526                
  NI               97.5 ± 11.8   98.7 ± 7.3    Unpaired *t*-test        0.746                
  TI               94.4 ± 10.4   91.3 ± 10.0   Mann--Whitney *U* test   0.461                
  TS               94.8 ± 9.5    94.1 ± 5.2    Mann--Whitney *U* test   0.854                
  Macular region   94.5 ± 8.0    92.3 ± 7.5    Unpaired *t*-test        0.444                
                                                                                             
  VS (%)           Overall       59.9 ± 6.7    62.4 ± 5.1               Unpaired *t*-test    0.248
  NS               62.2 ± 7.6    62.6 ± 6.7    Unpaired *t*-test        0.884                
  NI               60.9 ± 7.7    61.8 ± 7.0    Unpaired *t*-test        0.735                
  TI               52.4 ± 10.5   54.9 ± 4.7    Mann--Whitney *U* test   0.507                
  TS               61.2 ± 5.7    60.9 ± 12.5   Mann--Whitney *U* test   0.883                
  Macular region   62.2 ± 8.5    60.8 ± 5.7    Unpaired *t*-test        0.609                
                                                                                             
  AVS (%)          Overall       37.3 ± 6.4    33.2 ± 6.2               Unpaired *t*-test    0.083
  NS               38.2 ± 6.6    39.7 ± 12.6   Unpaired *t*-test        0.854                
  NI               36.6 ± 9.3    36.9 ± 12.4   Mann--Whitney *U* test   0.938                
  TI               42.0 ± 11.9   36.4 ± 7.8    Unpaired *t*-test        0.145                
  TS               33.6 ± 8.8    33.2 ± 13.4   Mann--Whitney *U* test   0.658                
  Macular region   32.3 ± 10.1   31.5 ± 7.1    Unpaired *t*-test        0.813                
                                                                                             
  AD (pixel)       Overall       13.2 ± 1.3    12.6 ± 1.0               Unpaired *t*-test    0.107
  NS               12.8 ± 1.6    12.8 ± 2.2    Unpaired *t*-test        0.886                
  NI               12.8 ± 1.9    12.0 ± 1.7    Unpaired *t*-test        0.233                
  TI               14.1 ± 2.7    13.4 ± 2.1    Unpaired *t*-test        0.450                
  TS               13.8 ± 2.2    12.7 ± 1.5    Unpaired *t*-test        0.116                
  Macular region   13.2 ± 1.3    12.8 ± 1.6    Unpaired *t*-test        0.373                
                                                                                             
  VD (pixel)       Overall       17.6 ± 1.5    16.8 ± 1.2               Unpaired *t*-test    0.152
  NS               17.1 ± 2.1    17.2 ± 2.2    Unpaired *t*-test        0.877                
  NI               16.0 ± 3.0    15.6 ± 2.8    Unpaired *t*-test        0.731                
  TI               20.3 ± 2.8    19.3 ± 2.1    Unpaired *t*-test        0.289                
  TS               18.0 ± 2.4    18.1 ± 3.1    Unpaired *t*-test        0.874                
  Macular region   15.8 ± 2.0    16.1 ± 1.9    Unpaired *t*-test        0.625                

###### 

Comparison of oxygen saturation and vessel diameter of the contralateral eyes between acute and chronic CSC patients.

                   Variables     Acute CSC     Chronic CSC              Statistical method   *p* value
  ---------------- ------------- ------------- ------------------------ -------------------- -----------
  AS (%)           Overall       95.9 ± 6.6    94.6 ± 7.0               Unpaired *t*-test    0.591
  NS               98.4 ± 7.0    99.7 ± 9.7    Unpaired *t*-test        0.660                
  NI               98.5 ± 11.3   98.5 ± 12.4   Unpaired *t*-test        0.992                
  TI               88.4 ± 8.1    89.2 ± 7.5    Unpaired *t*-test        0.764                
  TS               94.0 ± 6.6    91.7 ± 5.4    Unpaired *t*-test        0.300                
  Macular region   90.1 ± 5.3    88.6 ± 8.0    Mann--Whitney *U* test   0.397                
                                                                                             
  VS (%)           Overall       59.3 ± 7.2    58.2 ± 4.9               Unpaired *t*-test    0.645
  NS               62.0 ± 9.0    59.4 ± 4.5    Mann--Whitney *U* test   0.418                
  NI               58.0 ± 6.8    55.4 ± 6.0    Mann--Whitney *U* test   0.269                
  TI               52.8 ± 9.0    52.7 ± 9.4    Unpaired *t*-test        0.996                
  TS               62.5 ± 9.1    59.5 ± 7.7    Mann--Whitney *U* test   0.357                
  Macular region   60.2 ± 7.4    57.5 ± 8.9    Unpaired *t*-test        0.339                
                                                                                             
  AVS (%)          Overall       36.7 ± 5.8    36.4 ± 7.3               Unpaired *t*-test    0.914
  NS               36.4 ± 8.7    40.2 ± 10.9   Unpaired *t*-test        0.269                
  NI               40.5 ± 10.4   43.1 ± 12.5   Unpaired *t*-test        0.520                
  TI               35.6 ± 9.0    36.5 ± 11.6   Unpaired *t*-test        0.812                
  TS               31.5 ± 8.7    32.1 ± 8.6    Mann--Whitney *U* test   0.685                
  Macular region   29.9 ± 8.4    31.2 ± 9.1    Unpaired *t*-test        0.685                
                                                                                             
  AD (pixel)       Overall       13.0 ± 1.2    13.1 ± 1.4               Unpaired *t*-test    0.838
  NS               12.8 ± 1.7    13.3 ± 2.1    Unpaired *t*-test        0.385                
  NI               12.9 ± 1.8    12.4 ± 1.5    Unpaired *t*-test        0.433                
  TI               14.2 ± 2.5    13.1 ± 2.5    Mann--Whitney *U* test   0.185                
  TS               13.9 ± 1.7    14.8 ± 2.4    Unpaired *t*-test        0.218                
  Macular region   13.0 ± 1.5    12.7 ± 1.8    Unpaired *t*-test        0.595                
                                                                                             
  VD (pixel)       Overall       16.7 ± 1.6    17.0 ± 1.9               Unpaired *t*-test    0.598
  NS               16.8 ± 2.2    16.6 ± 2.4    Unpaired *t*-test        0.780                
  NI               15.7 ± 2.5    16.7 ± 3.1    Mann--Whitney *U* test   0.377                
  TI               18.1 ± 3.3    18.1 ± 3.8    Unpaired *t*-test        0.973                
  TS               16.5 ± 2.9    17.9 ± 2.7    Unpaired *t*-test        0.182                
  Macular region   14.9 ± 2.8    16.3 ± 2.3    Unpaired *t*-test        0.131                

[^1]: Academic Editor: Enrico Peiretti
